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Methods: Human knee articular cartilage with its subchondral
bone was either obtained from a tissue bank or sampled during
surgery for total knee joint replacement. Tissues were immedi-
ately processed for in situ hybridization and immunohistology.
Fluorescence intensity was semi-quantiﬁed and values obtained
for PH-20 were normalized by those obtained for cell DNA by us-
ing DAPI. The severity of the OA disease process was evaluated
by using the histologic-histochemical grading system devised by
Mankin.
Results: In normal cartilage PH-20 mRNA and PH-20 protein
were only detected in few chondrocytes of the superﬁcial car-
tilage layer as well as in few osteoclasts and osteoblasts of
the subchondral bone. As the severity of the OA disease pro-
cess increased, chondrocytes of middle and deeper cartilage
layers expressed the enzyme both at the mRNA and protein
levels. Scores of the Mankin’s scale correlated signiﬁcantly with
the level of PH-20 expression as assessed by ﬂuorescence in-
tensity. The enzyme was also detected outside cartilage cells
mostly in areas exhibiting erosions and in areas surrounding
clefts. In specimens with moderate to severe OA lesions, one
could also detect the enzyme signal in subchondral bone and
in some connective tissues cells ﬁlling up the spaces between
bone trabeculae.
Conclusions: Our data provide evidence that the PH-20 pro-
duced by chondrocytes might be implicated in the degradation
of cartilage matrix during OA. Indeed, the enzyme not only de-
grades hyaluronan, the backbone of aggrecan aggrecates and
a backbone of the pericullar matrix, but also chondroitin sul-
fate chains. Our data also suggest that, in OA, other cell lines
present in subchondral bone areas might contribute to the local
production of PH-20.
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Purpose: Depletion of aggrecan is one of the earliest changes
observed in osteoarthritis (OA). Aggrecan is a chondroitin sulfate
and keratan sulfate-bearing proteoglycan. Aggrecan cleavage
by Aggrecanase results in the release of a large sulfated gly-
cosaminoglycan (sGAG)-containing aggrecan fragments which
diffuse out of the cartilage matrix. Inhibiting Aggrecanase activity
is an attractive therapeutic target. The purpose of this study was
to understand the effects of a selective Aggrecanase inhibitor on
the fate of existing and newly synthesized proteoglycan in human
osteoarthritic articular cartilage.
Methods: Human cartilage from total knee replacements har-
vested within 3 hours of surgery was used for this study (n=3
donors). Harvested cartilage was maintained in culture in the
presence or absence of a selective Aggrecanase inhibitor. Total
proteoglycan content of conditioned media or cartilage matrix
was measured as sGAG by a colorimetric assay with dimethyl-
methylene blue. Aggrecan released from the cartilage was fur-
ther characterized using a monoclonal antibody (BC-3) that rec-
ognizes the neoepitope generated by Aggrecanase-mediated
cleavage of aggrecan. Articular cartilage was cultured in the
presence of [35S]sulfate to enable localization and characteriza-
tion of newly synthesized aggrecan.
Results: Human osteoarthritic articular cartilage from joints un-
dergoing total knee replacement demonstrated signiﬁcant, on-
going aggrecanase activity evidenced by release of aggrecan
cleaved at the “aggrecanase cleavage site” (G373-374A). Incu-
bation in the presence of the selective Aggrecanase inhibitor
reduced total proteoglycan loss. Cleavage of newly synthesized
aggrecan was a signiﬁcant component of the degradative pro-
cess, and Aggrecanase inhibition resulted in increased incorpo-
ration of new proteoglycan into the cartilage matrix.
Conclusions: Aggrecanase activity is a characteristic of hu-
man osteoarthritis throughout the disease process. Inhibition
of Aggrecanase activity reduced release of aggrecan degrada-
tion products from the articular cartilage matrix. Because newly
synthesized aggrecan appeared to be especially susceptible to
degradation by Aggrecanases, selective Aggrecanase inhibition
resulted in a net increase in proteoglycan incorporation into the
matrix of human osteoarthritic cartilage. These results indicate
that inhibition of Aggrecanases will reduce aggrecan degrada-
tion in human osteoarthritric articular cartilage throughout the
disease process, and may also result in a net increase in extra-
cellular matrix proteoglycan.
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Purpose: Cartilage Oligomeric Matrix Protein (COMP) is a pro-
tein present in the cartilage matrix. It binds to chondrocytes
and collagen and is involved in interaction between chondro-
cytes and collagen and probably also in collagen ﬁbrillogenesis.
COMP is expressed more abundantly in OA cartilage than in
normal healthy cartilage. The present study was designed to
investigate the effect of growth factors on COMP deposition and
the inﬂuence of COMP on collagen deposition and mechanical
properties.
Methods: Bovine chondrocytes in alginate beads were cultured
with or without 25 ng/ml IGF1, TGFbeta2 or FGF2. COMP gene
expression was determined with quantitative RT-PCR. COMP
protein production was determined with ELISA and Western blot
(reducing and non-reducing). Human COMP (hCOMP) was also
overexpressed in bovine chondrocytes using lentiviral transfec-
tion. hCOMP gene expression, COMP, collagen and proteoglycan
deposition and mechanical properties were determined.
Results: Addition of TGFbeta2 resulted in more COMP gene
expression than the control condition without growth factors or
with addition of IGF1. The COMP deposition in alginate beads
and excretion in the culture medium was also increased with ad-
dition of TGFbeta2. FGF2 resulted in less and partially degraded
COMP. Lentiviral transfection with hCOMP resulted in elevated
gene expression of hCOMP and increased COMP levels in the
culture medium compared to untransfected cells. However, no
difference was seen in the COMP deposition in the alginate
bead. COMP overexpression also did not affect the deposition of
collagen and proteoglycans or the mechanical properties.
Conclusions: It appears that COMP overexpression is not suf-
ﬁcient to increase extracellular COMP deposition in chondrocyte
alginate culture. However, increased COMP deposition can be
achieved by addition of TGFbeta, suggesting that modiﬁcation of
other factors such as collagen type IX or matrillins is also needed
to increase COMP deposition in cartilage regeneration.
